Long before the genome was mapped, before investors went Internet crazy, even before color television, David and Alice Schwartz started a scientific supply company called Bio-Rad Laboratories. Now, 50 ...
Bio-Rad Laboratories BIO is something of a rarity: a small-cap company with a wide economic moat. The company develops products and solutions for the clinical diagnostics and life sciences industries, ...
I rate Bio-Rad (BIO) with a buy rating. I start by mentioning that the low growth perspective is the negative aspect. For 2025, the company expects a 0.25% growth rate for its revenues, which might ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback